🇺🇸 FDA
Patent

US 7074554

Antibodies specific for NEBR1 and methods of use thereof

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7074554 (Antibodies specific for NEBR1 and methods of use thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P31/18